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Abstract
This study investigated the biochemical suitability of Australian native microalgal species
Scenedesmus sp., Nannochloropsis sp., Dunaliella sp., and a chlorophytic polyculture as
nutritional supplements for human health. The four microalgal cultures were harvested dur-
ing exponential growth, lyophilized, and analysed for proximate composition (moisture, ash,
lipid, carbohydrates, and protein), pigments, and amino acid and fatty acid profiles. The re-
sulting nutritional value, based on biochemical composition, was compared to commercial
Spirulina and Chlorella products. The Australian native microalgae exhibited similar, and in
several cases superior, organic nutritional properties relative to the assessed commercial
products, with biochemical profiles rich in high-quality protein, nutritious polyunsaturated
fats (such as α-linolenic acid, arachidonic acid, and eicosapentaenoic acid), and antioxidant
pigments. These findings indicate that the microalgae assessed have great potential as
multi-nutrient human health supplements.
Introduction
There is well-founded, enormous potential for a greater variety of microalgal species to be uti-
lized in human nutrition. A myriad of microalgae contain protein of high quality for humans
[1]. Several of the most common microalgal pigments (chlorophyll, β-carotene, and lutein) are
beneficial to human health, possessing cancer prevention activity and functioning as antioxi-
dants and anti-inflammatories [2]. Nutritious polyunsaturated fatty acids also proliferate in
many algal species, providing essential fatty acids necessary for cardiovascular, ocular, and neu-
rological health [3]. Despite this potential, few microalgal species are currently utilized in the
human nutrition market.
Spirulina and Chlorella currently dominate this lucrative market, and are sold in over 20
countries worldwide [3]. Commonly sought nutraceuticals from these species include protein,
vitamins, pigments chlorophyll and β-carotene, and minerals. Spirulina in particular is mar-
keted for its protein, γ-linolenic acid (GLA) and phycocyanin content. Chlorella, on the other
hand, is advertised to provide the Chlorella Growth Factor (CGF), a water-soluble extract
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composed of a variety of substances including essential amino acids, peptides, proteins, vita-
mins, sugars, and nucleic acids [4].
Clinical and animal trials have revealed a variety of health benefits derived from Chlorella
and Spirulina consumption. Chlorella and its extracts containing the CGF are capable of pro-
moting growth rate, increasing insulin sensitivity, strengthening immune system function, and
preventing stress-induced ulcers and pregnancy-associated anemia and hypertension [5]. The
exact mechanisms behind these Chlorella health benefits are not well understood, but have
been attributed to a combined effect of multiple nutrients [6]. Spirulina can improve hemoglo-
bin, protein, and vitamin levels in malnourished children, alleviate vitamin-A deficiency
through provision of bioavailable β-carotene, and favourably affect antioxidant capacity, im-
mune function, and anemia status [7]. Positive health influences of Cyanobacteria, including
Spirulina, have been attributed to fiber components, phycocyanin, γ-linolenic acid, vitamins,
phenolic compounds, and minerals [8]. The resulting health benefits from these studies have
provided the means to successfully market these microalgae to the public as multi-
nutrient supplements.
The microalgae Nannochloropsis sp., Scenedesmus sp., and Dunaliella sp. are utilized for
large-scale applications in the biofuel and aquaculture industries, but Nannochloropsis sp. and
Scenedesmus sp. are not widely produced for human health. Although global production of
Dunaliella sp. for human nutrition is on the rise, current estimates of microalgae production
show that Spirulina and Chlorella exceed Dunaliella in ton/year production by ten and four-
fold, respectively [9]. Productivity, growth media requirements, environmental tolerances, and
other culturing data are already established for Nannochloropsis sp., Scenedesmus sp., and
Dunaliella sp., creating the potential for efficient production, or expansion in production, of
nutraceutical biomass. Australia, with its abundant sunshine and non-arable land, is a suitable
prospective location for cultivation [10].
Current findings highlight individual nutritious biochemical components of Nannochlorop-
sis sp., Scenedesmus sp., and Dunaliella sp., and initial food acceptability, preparation, and ani-
mal and human trials indicate that they may have an opportune future in health food
applications. Nannochloropsis sp., and Scenedesmus sp., have previously been suggested for nu-
traceutical application due to their concentrations of the nutritious fatty acid eicosapentaenoic
acid (EPA), and vitamins and essential minerals, respectively [11,12]. Dunaliella sp. is princi-
pally highlighted in nutrition for its ability to accumulate high concentrations of carotenes and
xanthophylls [5]. Acceptability studies utilizing Scenedesmus sp. as a protein supplement for
humans have yielded principally positive results [13]. In rat trials, Scenedesmus acutus signifi-
cantly improved growth in wheat and bread diets when utilized as a protein supplement [14],
and has been shown to contain comparable protein efficiency ratios, biological values (measure
of nitrogen retained for growth and maintenance), and digestibility coefficients (measures pro-
tein quality) to Spirulina and Chlorella [1]. Nannochloropsis sp. and Dunaliella bardawil sup-
plementation in rats was innocuous when fed in quantities as high as 10% of their diet [11,15].
Other rat nutrition studies have shown that plasma cholesterol, triglycerides and creatine phos-
phokinase levels could be significantly lowered when Dunaliella tertiolecta was used as the sole
protein source for just 12 days [16]. Studies have highlighted the capacity for β-carotene from
Dunaliella species to act as an antioxidant or anti-hyperlipidemic, and for EPA from Nanno-
chloropsis oculata to elevate EPA level in human blood, but no known studies have tested other
nutritious components of either algae in human trials [17].
Methods for breaking Scenedesmus obliquus and Scenedesmus quadricauda cell walls, drying
biomass, and food preparation in order to increase digestibility and nutrient availability have
already been determined, much like commercially-produced Chlorella vulgaris [18,19]. Fur-
thermore, Scenedesmus sp. and Dunaliella sp. have attractive taste similar to Chlorella vulgaris,
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and would do well when incorporated into many foods, such as pasta, pretzels, potato and corn
chips, soups and seasonings, an assortment of dairy products, and even candies and ice creams
[13].
Microalgal polycultures, especially photoautotrophic mixes, are commonly utilized in aqua-
culture systems as a source of nutrition for fish and crustaceans, and in bioremediation [20,21].
To our knowledge they have yet to be cultivated for human nutrition, however, supplements
are currently sold which combine several microalgal species in one multi-nutrient supplement.
The ability to culture a microalgal polyculture for nutritional applications may provide several
advantages over monoculture production, including increased productivity and robustness to
predation by contaminants such as rotifers due to variation in cell size and structure [22].
Although individual nutrients (such as specific fatty acids or antioxidant pigments) have
been highlighted as nutritious components in Nannochloropsis sp., Scenedesmus sp., and Duna-
liella sp., and initial focused animal and human trials are promising, it is unclear whether these
microalgae are suitable for human nutrition in a multi-nutrient capacity like commercially pro-
duced Spirulina and Chlorella. Furthermore, no knowledge is currently available regarding
whether microalgal polycultures could also merit consideration in human
nutrition applications.
Although biochemical composition data may be available for Spirulina and Chlorella prod-
ucts, it is essential to re-assess their composition for an accurate comparison to the microalgae
tested in this work since differing methods utilized for biochemical profiling in nutrition label-
ling and scientific publication, especially in the cases of protein and carbohydrate content(s),
are known to yield variable results [23,24]. This study aimed to determine the biochemical suit-
ability of Australian microalgae, Scenedesmus sp., Nannochloropsis sp., and Dunaliella sp., plus
a unique chlorophytic polyculture (CPC) for human nutrition through examination of bio-
chemical profiles and comparison to existing commercially available Chlorella and
Spirulina products.
Materials and Methods
Microalgae growth and sample preparation
This study was conducted at the James Cook University/MBD Energy (JCU/MBD) Microalgae
Research and Development Facility (146°45&rsquo;38"E, 19°19&rsquo;39"S). Microalgae Sce-
nedesmus sp., Nannochloropsis sp., Dunaliella sp., and a designed freshwater chlorophytic poly-
culture (CPC; consisting of Schroederiella apiculata, Scenedesmus pectinatus, Tetraedrom
minimum,Mesotaenium sp. and Desmodesmus sp.) were isolated from various locations in
Australia (no specific collection permissions were required) (Table 1) and DNA-sequenced by
Macrogen (Seoul, Korea). These microalgae were batch-cultured in three replicate vertical,
Table 1. Culturing parameters for each James Cook University/MBD Energy (JCU/MBD) microalgae.
Nannochloropsis
sp.
Scenedesmus sp. Dunaliella sp. CPCa
Media f/2 [27] Bold Basal Medium [28] Modified Johnson Media [29] Bold Basal Medium [28]
Salinity 36ppt 2ppt 36ppt 2ppt
Australian isolate
origin
Great Barrier Reef Tarong Power Station,
Queensland
Pink Lake; Goldsfields-Esperance region,
Western Australia
Tarong Power Station,
Queensland
a Chlorophytic polyculture (CPC) species—Schroederiella apiculata, Scenedesmus pectinatus, Tetraedrom minimum, Mesotaenium sp. and
Desmodesmus sp.- were isolated from the same location.
doi:10.1371/journal.pone.0118985.t001
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conical-based fibreglass (40cm diameter, 3m height, 320L volume) photobioreactors with cen-
tral aeration, utilizing media as depicted in Table 1. Culture pH was maintained at 6.5–7.5 and
7.5–8.5 by injection of CO2 for 2 ppt and 36 ppt cultures, respectively. Microalgal cultures were
grown at a mean temperature of 25°C, under a light:dark regime of 18:6 hours and a photon
flux density of 80 μmol m2 s-1. Growth was established for each algal culture using cell counts
with a Neubauer hemocytometer and gravimetric dry weight determination. All cultures were
harvested by centrifugation at exponential growth phase to optimize protein and highly-
unsaturated fatty acid content. Post-harvest, the microalgal biomass was lyophilized and kept
in air-tight containers in darkness at -80°C for subsequent biochemical profiling analyses. The
drying method of choice for commercial producers of high-value microalgae products such as
Spirulina and Chlorella is spray-drying [25], however, lyophilized microalgal biomass has been
found to be similar to spray-dried biomass in elemental composition and contents of protein,
carbohydrates, chlorophylls, and fatty acids [26]- therefore drying method was not a variable
for the purpose of this study.
Four Spirulina (from producers in China, India, Taiwan, and the USA) and three Chlorella
(from producers in Japan, South Korea, and Germany) supplement powders containing only
100% pure Spirulina platensis or Chlorella vulgaris, respectively, were purchased in May 2013,
to act as references for commercial microalgal products. These commercial products were kept
unopened in darkness at 20°C until commencement of biochemical profiling. Once products
were opened, an aliquot of the product was maintained in darkness in an airtight container at
-80°C for biochemical profiling. For biochemical quantification and statistical analysis the four
Spirulina and three Chlorella products were treated as replicates.
Biochemical composition
Fatty acid (FA) analysis. FA analyses were performed in duplicate for each replicate sample,
and biochemical results are presented as mean values. FAs were simultaneously extracted and
esterified in a direct transesterification method, as described in detail in Gosch et al. [30]. The
resulting fatty acid methyl esters (FAMEs) were separated and quantified on an Agilent 7890
GC (DB-23 capillary column, 60 m x 0.25 mm I.D. x 0.15 μm) and an Agilent 5975C Electron
Ionisation (EI) Turbo Mass Spectrometer (Agilent Technologies Australia Pty Ltd). The col-
umn temperature gradient was programmed following David et al. [31], ramping from 50°C to
250°C. The quantity and identity of fatty acids were determined using external standards
(Sigma Aldrich) and NIST08 Mass Spectral Library, and corrected for recovery of internal stan-
dard (C19:0). Total FA content was determined as the sum of all FAMEs.
Pigment analysis. Pigments were assessed via methods adapted from Van Heukelem and
Thomas [32] utilizing the studies’ top-performing column, running solvents and column flow
rate, but with modified extraction and gradient system. All pigment extraction procedure steps
were performed on ice in dimmed light. Twenty mg of each sample was extracted with metha-
nol: 0.5 M tert-Butyl acetoacetate (TBAA) (99:1 v/v) using mechanical disruption via zirconi-
um beads agitated by a bullet blender (model BBY24M). After bead disruption, samples were
centrifuged (Sigma 1–14 Microfuge) at 13000 rpm for 5 minutes, and supernatant was re-
moved. A cycle of bead disruption, centrifugation, and supernatant removal was repeated until
sample pellet and supernatant were colourless. An aliquot of the combined pigment extract
was then diluted by 71% with 28 mM TBAA (pH 6.5) and 100 μL of the solution was injected
onto a 60°C Agilent Eclipse XDB C-8 (4.6 x 150 mm; 3.5 μm) column on a Varian Prostar
HPLC with Varian Prostar UV-Viz detector and Metachem Degassit degasser unit at a flow
rate of 1 ml min-1. The HPLC solvent system was set as follows: 5% methanol (100%) (solvent
B): 95% methanol and 28 mM TBAA pH 6.5 70:30 (v/v) (solvent A) for 0–15 minutes; 50%
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solvent B and 50% solvent A for 15–38 minutes; 95% solvent B and 5% solvent A for 38–45
minutes; 100% solvent B for 45–47 minutes; 5% solvent B and 95% solvent A for 47–52 min-
utes. Pigments were detected at 440 nm and identified by comparison with retention times of
phytoplankton standards (DHI Laboratory Products, Denmark). In this work the chlorophyll
summation was defined as the sum of chlorophylls a and b, while the carotenoid summation
was defined as the sum of astaxanthin, lutein, zeaxanthin, echinenone, and β-carotene. Astax-
anthin and β-carotene results were also reported individually since these carotenoids are of
particular interest for health food applications due to their well-known properties as antioxi-
dants [33].
Amino acid analysis. Equal portions of each replicate were pooled to form one amalgamat-
ed sample of each microalgal species for amino acid analysis. Amino acid profile of each sample
was analysed by the Instrument Analysis Center of Shanghai Jiao Tong University, utilizing a
Hitachi L8900 Amino Acid Analyzer (Tokyo, Japan) according to the Chinese national stan-
dard protocol for amino acid determination (GB/T 5009.124–2003). Briefly, 10 mg of each
sample was hydrolysed in a vacuum glass tube using 6 M HCl at 110°C for 22h. Samples were
then dried in a vacuum, and the residue was diluted with 0.02 M HCl prior to analysis on the
amino acid analyser, together with amino acid standards. In this work, protein was measured
in the method currently recommended by the FAO- the sum of amino acids [34]-
excluding tryptophan.
Essential amino acid index (EAAI). EAAI scores were calculated to indicate protein quality
as in Tabarsa et al. [35] using a FAO/WHO established human reference pattern [36]. EAAI
scores represented protein quality by comparing ratios of essential amino acids in a food item
to those of a reference pattern derived from whole body tissue of the animal [36]. In EAAI
computation, index scores approaching 1 represented the closest possible match between a
food’s essential amino acid profile and the consumer. In the evaluation, a score of ~> 0.95 de-
fined a ‘high’ quality protein, while a score of ~ 0.86–0.95 signified a ‘good’ quality protein, a
score of ~ 0.75–0.86 signified a ‘useful’ protein, and a score of ~ 0.75 indicated an ‘inade-
quate’ protein [37].
Proximate analysis. Ash, moisture, crude protein, crude fat, and a measure representing
sugars and starches (carbohydrates) were analysed to determine proximate composition; crude
fiber was not assessed as it is not recommended for inclusion in food composition databases
[34]. The proximate system of analysis is commonly utilized for providing a broad classifica-
tion of food components in nutrition and forms the basis for legislative regulation of food anal-
ysis in many countries [34]. Proximate analyses were performed in duplicate for each sample,
and biochemical values are presented as means in the results. Carbohydrates were analyzed uti-
lizing a colorimetric technique approved by the FAO [34]- the phenol-sulphuric acid spectro-
photometric method. Lipids were extracted from samples via direct extraction by methods
modified from Lewis et al. [38] to use less toxic solvents (methanol and hexane), as in Carvalho
and Malcata [39]. Total lipid extraction recovered neutral lipids, phospholipids, glycolipids,
and pigments. Moisture and ash content were determined gravimetrically after algal biomass
was exposed to 100°C in a Qualtex Thermostat z670 drying oven for 2 hours, and 500°C in a
Yokogawa model UP150 muffle furnace for 8 hours, respectively.
Statistical Analysis
All statistical analyses on individual biochemical parameter data were carried out using IBM
SPSS Statistics 20. The assumptions of homogeneity of variance and normality were assessed
by scatter plots of residuals and normal curves of residuals, respectively. Proportional data
were arcsine-square root transformed to meet ANOVA assumptions. One-way ANOVAs with
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Tukey HSD post-hocs were utilized to discern differences between groups. Principle Compo-
nent Analysis (PCA) was conducted using Primer 6 on all biochemical parameter data (except-
ing amino acid data due to pooled replicates) to better understand how individual parameters
drove differences between algal samples. The data for PCA was normalized on a common mea-
surement scale. A subsequent permutational multivariate analysis of variance (PERMANOVA)
and pair-wise comparisons were used to detect significant differences between samples. Differ-
ences were deemed significant at p< 0.05.
Results and Discussion
PCA analysis demonstrated biochemical similarity through clustering between Chlorella prod-
ucts, Dunaliella sp., CPC, and Scenedesmus sp. Spirulina products (PERMANOVA; p< 0.05)
and Nannochloropsis sp. (PERMANOVA; p> 0.05) were divergent from all other microalgae.
These divergences were driven by GLA and O-3 FA content (lack of) in Spirulina and high
EPA, arachidonic acid (ARA), and astaxanthin content in Nannochloropsis sp. (Fig. 1). PER-
MANOVA analysis of biochemical values also demonstrated similarities between all JCU/
MBD microalgae and Chlorella products (p> 0.05). These findings indicate that the JCU/
MBD microalgae presented here- Dunaliella sp., Nannochloropsis sp., Scenedesmus sp., and the
Fig 1. Principal component analysis (PCA) depicting extent of differences in biochemical parameters between James Cook University/MBD
Energy (JCU/MBD) microalgae (Nannochloropsis sp.,Dunaliella sp., Scenedesmus sp., and the CPC) and commercial microalgae products, which
are indicated by the length of radiating lines. Biochemical parameters corresponding to the radiating lines pointing towards species indicate parameters of
similarity, while opposite radiating lines indicate dissimilarity.
doi:10.1371/journal.pone.0118985.g001
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CPC- exhibited comparable, and in several cases superior, organic nutritional properties rela-
tive to Spirulina or Chlorella commercial microalgal products.
Fatty acids
All JCU/MBD microalgae were superior to one or both commercial microalgal products in
terms of total O-3 FA content: Nannochloropsis sp. and the CPC contained significantly greater
O-3 FA content than Chlorella products (p< 0.05; Table 2), and all JCU/MBD microalgae con-
tained significantly greater O-3 FA content than Spirulina products, which contained no de-
tectable O-3 FAs (Table 2).
The higher O-3 FA content of JCU/MBD microalgae relative to commercial products was
driven by elevated concentrations of nutritious, long-chain essentialO-3 FAs. All JCU/MBD
microalgae were rich (> 2% dry weight) in either EPA or α-linolenic acid (ALA) (Table 2). Hu-
mans are incapable of synthesizing ALA de novo [40], and can only inefficiently synthesize
EPA from precursor ALA [41], thus provision of these fatty acids in our diet is essential. Quan-
tities of the FAs ARA and EPA were significantly higher in Nannochloropsis sp. than in all
other microalgae samples (p< 0.05; Table 2). At a mean of 3.68% (dry weight), the quantity of
EPA achieved in Nannochloropsis sp. biomass was more than 100-fold greater than in all other
samples tested. This concentration of EPA is within the range of 3.18–4.33% recently achieved
by researchers aiming to produce high quantities of EPA in Nannochloropsis sp. [42]. The
CPC, Scenedesmus sp., and Dunaliella sp. contained significantly greater quantities of essential
FA ALA than either commercial product species (p<0.05), while Spirulina products contained
significantly greater quantities of the O-6 FA, γ-linolenic acid (GLA) than all other samples
(p< 0.05). All microalgae contained similar amounts of cis-linoleic acid (LA) (p> 0.05), apart
from Nannochloropsis sp. which contained significantly less (p< 0.05; Table 2). Docosahexae-
noic acid (DHA) was not detected in any of the microalgal samples.
Table 2. Mean fatty acid (FA) content (mg g-1 dry weight) of nutritious FAs, proportion of polyunsaturated FAs (PUFA; % of total FAs), ratio of Ω-
6/Ω-3 FAs, and FA totals (mg g-1 dry weight) in James Cook University/MBD Energy (JCU/MBD) microalgae and commercial microalgae
products (mean ± SD, n = 3).
JCU/MBD Microalgae Products
Nannochloropsis sp. Scenedesmus sp. Dunaliella sp. CPC Spirulina Chlorella
ALA (C18:3 n-3)a 0.23 ±0.11a, b 21.22 ±6.88b, c, d 21.18 ±4.28b, c, d 23.70 ±2.53c, d NDa, b 10.35 ±8.24a, b, c
ARA (C20:4 n-6)b 7.45 ±1.79b NDa NDa 0.41 ±0.09a NDa NDa
EPA (C20:5 n-3)c 36.76 ±2.93b 0.11 ±0.19a NDa 0.51 ±0.06a NDa NDa
GLA (C18:3 n-6)d 0.82 ±0.3a, b, c 0.49 ±0.16a, b, c 2.53 ±0.59b, c 0.61 ±0.20a, b, c 9.42 ±1.52d NDa, b
LA (C18:2 n-6)e 4.11 ±1.46a, b, c 6.19 ±2.90a, b, c, d, e 8.43 ±3.72a, b, c, d, e 4.46 ±1.11a, b, c, d 10.62 ±1.40b, c, d, e 18.45 ±11.80c, d, e
PUFA (% FA) 44.64 ±3.35a, b 51.14 ±7.04a, b, c 71.67 ±2.40c, d 65.69 ±1.96b, c, d 41.60 ±1.01a, b 70.59 ±3.21c, d
Ω-6/Ω-3 Ratio 0.35 ±0.05 0.22 ±0.08 0.43 ±0.20 0.17 ±0.02 Undefined 7.20 ±11.16
Total Ω-3 FA 36.99 ±1.75c, d 34.21 ±6.08b, c, d 33.05 ±3.88b, c, d 36.70 ±3.52c, d NDa, b 15.84 ±7.20a, b, c
Total FA 114.57 ±9.02d 82.08 ±7.65b, c 66.32 ±5.00a, b, c 66.39 ±5.05a, b, c 48.73 ±1.14a, b 60.60 ±3.26a, b, c
Values in rows with different superscripts represent significant differences between microalgal samples (p < 0.05). ND signifies ‘not detected’.
a α-Linolenic acid
b Arachidonic acid
c Eicosapentaenoic acid
d γ-Linolenic acid
e Linoleic acid.
doi:10.1371/journal.pone.0118985.t002
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Essential FAs (especially EPA and DHA) are known to be beneficial for human health, re-
ducing the rate of occurrence and lowering the risk of cardiovascular and artery diseases, de-
creasing levels of blood cholesterol, providing for maximal brain function and visual acuity
(especially in infants), and reducing inflammation and arthritis [43]. Therefore, the content of
these FAs is nutritionally critical for evaluating microalgal potential for human health benefit.
PUFA content was similar between Nannochloropsis sp., Scenedesmus sp., and Spirulina
products, ranging from 41.60–51.14% of fatty acid content (p> 0.05). Dunaliella sp., the CPC,
and Chlorella products contained greater PUFA content representing 65.69–71.67% of fatty
acids (p> 0.05). All JCU/MBD microalgae were comparable in total FA content to commercial
products (p> 0.05) except for Nannochloropsis, which contained significantly greater total
fatty acid content (p< 0.05; Table 2).
O-6/O-3 ratios in all JCU/MBD microalgae were within the range recommended as most
beneficial for human health, 0.25–1 (Table 2) [44]. Ratios in commercial products, however,
exceeded recommended levels, with highly variable Chlorella ratios (averaging 7.2) and Spiru-
lina ratios as undefined, since no O-3 FAs were present to balance the 20.04 ±1.97 mg g-1 of O-
6s in Spirulina samples. Due to competition for desaturation enzymes, a balance between O-6
and O-3 FA in foods is essential for human health benefits to be conveyed, and high O-6/O-3
ratios have been implicated in the promotion of cardiovascular disease, cancer, and inflamma-
tory and autoimmune diseases [44]. This signifies that in addition to having high essential fatty
acid content, JCU/MBD microalgae assessed were superior to the commercial products as-
sessed in terms of O-6/O-3 balance.
Pigments
Nannochloropsis sp. and Dunaliella sp. had a significantly greater sum of carotenoids than both
commercial products (p< 0.05), whereas other JCU/MBD microalgae were similar in caroten-
oid content to products (p> 0.05; Table 3). Nannochloropsis sp. also contained significantly
greater quantities of the nutritious carotenoid astaxanthin than all microalgae sampled
(p< 0.05, Table 3). At a level of 0.64% dry weight, astaxanthin content of Nannochloropsis sp.
found in this study nears the level of 0.7% achieved by Lubian et al. [45], supporting the conclu-
sion that Nannochloropsis could be a source of valuable pigments due to its ability to achieve
high production levels of a range of pigments- including astaxanthin. All microalgae samples
contained equivalent minimal β-carotene content (p> 0.05, Table 3). Although JCU/MBD
microalgae contained higher mean chlorophyll content than commercial products, the differ-
ences were not significant (p> 0.05; Table 3). Nevertheless, the JCU/MBD microalgae pre-
sented here, especially Nannochloropsis sp., proved to be rich sources of chlorophyll,
Table 3. Mean pigment content (mg g-1 dry weight) of James Cook University/MBD Energy (JCU/MBD) microalgae and commercial microalgae
products (mean ± SD, n = 3).
JCU/MBD Microalgae Products
Nannochloropsis sp. Scenedesmus sp. Dunaliella sp. CPC Spirulina Chlorella
Chlorophyll summation 30.54 ± 4.36a 19.00 ± 7.13a 23.65 ± 8.68a 24.97 ± 4.25a 12.33 ± 1.09a 8.58 ± 0.33a
Carotenoid summation 8.57 ± 1.56c, d 4.23 ± 0.81a, b, c 5.12 ± 0.72b, c, d 3.82 ± 0.42a, b, c 1.45 ± 0.38a, b 1.17 ± 0.44a, b
Astaxanthin 6.40 ± 1.20b 1.50 ± 0.32a 0.83 ± 0.33a 0.75 ± 0.22a NDa 0.08 ± 0.03a
β-carotene 0.67 ± 0.15a 0.70 ± 0.13a 1.02 ± 0.28a 0.73 ± 0.09a 0.92 ± 0.30a 0.19 ± 0.09a
Values in rows with different superscripts represent significant differences between microalgal samples (p < 0.05). ND signifies ‘not detected’.
doi:10.1371/journal.pone.0118985.t003
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astaxanthin, and carotenoids, all widely recognized for their antioxidant and antimutagenic
properties [2].
Protein content and quality
Amalgamated protein content was highest in Spirulina products, followed by Chlorella prod-
ucts, the CPC, Dunaliella sp., Scenedesmus sp., and Nannochloropsis sp. (Table 4). Nevertheless,
with protein content ranging from 30–52%, all JCU/MBD microalgae evaluated, as well as the
commercial products, exceeded the 20% (dry weight) protein supplement baseline established
by the Ontario Ministry of Agriculture and Food for animal feeds [46]. As of yet there is no es-
tablished numerical baseline to define a human protein supplement.
Protein quality for human nutrition, according to EAAI scores, was ‘high’ for all four JCU/
MBD microalgae (Table 5). Commercial products contained protein of slightly lower quality:
protein in Chlorella products was classified as ‘good’ quality protein, while Spirulina products
contained ‘useful’ protein (Table 5). EAAI scores were higher in JCU/MBD microalgae princi-
pally due to higher proportions of the essential amino acids histidine and phenylalanine. Addi-
tionally, JCU/MBD microalgae had a higher proportion of threonine than that in Chlorella
products (Nannochloropsis sp. marginally), and also higher proportions of lysine and slightly
higher leucine than Spirulina products (Table 5). Across all microalgal samples the dominant
amino acid was glutamic acid and the limiting amino acid was cysteine (Table 5), a common
trend in microalgae [47].
Proximate composition
Proximate composition was comparable between most JCU/MBD microalgae and commercial
Spirulina and Chlorella products (Table 4).
All JCU/MBD microalgae had similar carbohydrate content to either Spirulina or Chlorella
products (p> 0.05; Table 4). Algal carbohydrates can provide human health benefits in the
form of anticoagulants, antivirals, dietary fibers, and antioxidants [48]. Carbohydrates are not
sought after as a large percentage of commercial microalgal supplements, however, since large
quantities of carbohydrates correspond to lower fractions of other macronutrients in the sup-
plement, most notably protein.
All JCU/MBD microalgae, apart from Nannochloropsis sp., also had comparable total lipid
values to one of the two commercial product species (p> 0.05; Table 4). Nannochloropsis sp.
contained higher total lipid content than all commercial microalgal products (p< 0.05).
Table 4. Mean (% of dry weight) proximate biochemical composition of James Cook University/MBD Energy (JCU/MBD) microalgae and
commercial microalgae products (mean ± SD, n = 3).
JCU/MBD Microalgae Products
Nannochloropsis sp. Scenedesmus sp. Dunaliella sp. CPC Spirulina Chlorella
Ash 11.32 ± 4.32a, b, c 15.72 ± 8.63a, b, c 19.29 ± 7.91b, c 7.96 ± 1.51a, b, c 7.02 ± 0.77a, b 5.71 ± 1.71a, b
Carbohydrates 9.62 ± 1.24a, b, c 27.66 ± 4.48c, d, e 14.57 ± 4.79a, b, c, d 18.70 ± 1.26a, b, c, d, e 16.00 ± 1.60a, b, c, d 24.93 ± 7.23b, c, d, e
Total Lipid 21.78 ± 1.71d 15.07 ± 1.63b, c 14.36 ± 2.21a, b, c 16.43 ± 0.40b, c 11.18 ± 0.37a, b 16.15 ± 2.06b, c
Moisture 1.84 ± 2.38a 0.71 ± 0.83a 4.05 ± 6.46a 2.31 ± 2.60a 2.59 ± 0.75a 1.30 ± 0.58a
Proteina 30.29 30.99 34.17 37.55 51.56 39.98
Values in rows with different superscripts represent significant differences between microalgal samples (p < 0.05).
aProtein results do not include SD since replicates were pooled for analysis.
doi:10.1371/journal.pone.0118985.t004
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Although the value for total lipid may be of limited nutritional significance since it assesses the
quantity of a group of compounds including fatty acids, sterols, vitamins, pigments, and other
lipid-solvent soluble substances, it is still widely reported and retained for food labelling and
regulatory purposes [34]- and so is utilized in this work as one of the indicators of nutritional
similarity between commercial microalgal products and JCU/MBD microalgae.
All microalgal samples showed a similar moisture content of below 5% (dry weight)
(p> 0.05; Table 4). The ability to produce a microalgal powder with low moisture content is
important for preservation of nutritional integrity, since presence of liquid water can encourage
microbiological activity and deterioration of food products. In this regard, JCU/MBDmicroal-
gae had similar quality to Chlorella and Spirulina commercial products.
Ash content was also similar between all microalgal groups (p> 0.05; Table 4) except for
Dunaliella sp., which contained greater ash content than both commercial products (p< 0.05,
Table 4). Ash content of all microalgae tested was, nevertheless, lower than the maximum al-
lowed in algal products sold in the USA (45% dry weight), and comparable or slightly greater
than in land vegetables (5–10% dry weight) [49]. Overly high ash content in foods is generally
undesirable; however, algal ash can contribute to meeting the recommended daily intake of
minerals in human nutrition [50].
For future consideration of microalgal species in human nutrition, elemental and trace
metal analysis would need to be undertaken to identify specific nutritious trace elements and
ensure that safe limits of heavy metals are not exceeded. Elemental composition, as well as vita-
min content, were not analysed in this work since mineral and vitamin content of microalgae
Table 5. Amino acid residue content (mg g-1 dry weight) and essential amino acid index (EAAI) value of James Cook University/MBD Energy
(JCU/MBD) microalgae and commercial microalgae products.
JCU/MBD Microalgae Products
Nannochloropsis sp. Scenedesmus sp. Dunaliella sp. CPC Spirulina Chlorella
Histidine* 26.26 26.06 25.03 27.79 20.07 24.32
Serine 42.14 45.51 43.97 45.49 48.05 40.40
Arginine 60.82 64.13 65.92 65.42 75.86 71.46
Glycine 52.12 55.98 57.04 57.15 45.58 53.84
Aspartic acid 91.56 101.89 105.05 104.32 101.82 93.64
Glutamic acid 137.82 129.37 136.11 122.80 160.59 128.88
Threonine* 48.56 56.27 50.53 53.06 51.10 47.38
Alanine 68.20 81.11 77.65 78.40 73.76 83.40
Proline 82.77 48.36 49.06 48.79 32.63 47.83
Lysine* 68.31 66.61 62.00 71.61 50.94 88.87
Tyrosine* 39.74 43.40 40.65 43.15 47.82 41.60
Methionine* 23.60 24.44 25.28 23.87 28.82 22.30
Valine* 60.24 61.76 59.83 61.59 63.64 61.02
Isoleucine* 47.22 44.10 45.08 44.24 58.37 43.98
Leucine* 94.05 91.89 93.22 92.05 90.23 92.00
Phenylalanine* 55.26 55.72 59.59 58.23 47.87 54.73
Cysteine* 1.32 3.40 3.98 2.03 2.87 4.35
Total 302.95 309.85 341.68 375.50 515.65 399.78
EAAI 1.02 1.00 0.98 1.05 0.81 0.92
Asterisks (*) indicate essential amino acids. Values in italics denote the limiting amino acid in each microalga.
doi:10.1371/journal.pone.0118985.t005
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are known to be directly related to levels of both in the microalgal growth environment [51,52],
and so can be manipulated by the grower to ensure that correct levels are achieved.
Application
Dunaliella sp., Scenedesmus sp., and (especially) Nannochloropsis sp., were found to have nutri-
tious biochemical profiles, and all have the potential for conversion to, or expansion of, pro-
duction for human nutrition due to their established cultivation histories in aquaculture,
biofuels, or targeted nutraceuticals. This work also demonstrated that the amalgam of microal-
gae in the CPC (Schroederiella apiculata, Scenedesmus pectinatus, Tetraedrom minimum,Meso-
taenium sp. and Desmodesmus sp.) was comparable in most organic nutrient aspects- and
superior in ALA and O-3 FA content- to the commercially produced microalgal supplement
products. Although the growth of microalgal polycultures may have some cultivation advan-
tages (as previously stated), species composition and dominance have the ability to adjust in re-
sponse to environmental change, which could likely affect overall biochemical composition of
the biomass. Additional analyses, therefore, need to be completed to determine the degree of
variability of the CPC nutritional results.
These findings warrant an expansion in exploration of the health benefits which may be possi-
ble by consuming Dunaliella sp., Scenedesmus sp., andNannochloropsis sp. in whole or cracked-
cell form. Like commercially produced Spirulina and Chlorella, they too may have multiple
health benefits which may be conveyed by their various nutritional properties. Furthermore, uti-
lization of whole or cracked-cell microalgae for supplement production may be more economical
and environmentally sound than production of an alga for a singular nutritive compound, since
it omits the large expenses and chemicals that can be needed for biorefinery-extraction
and processing.
Current research also suggests that Chlorella, Scenedesmus, and Dunaliella are capable of
producing recombinant proteins at levels similar to the model microalgae Chlamydomonas
reinhardtii, which could lead to their use in production of antibodies, immunotoxins for use in
anti-cancer therapy, growth hormones, vaccines, gut-active nutraceuticals, and therapeutic en-
zymes [53]. Recent innovations in genetics have yielded the potential for improvement of the
already nutritious biochemical profiles of these microalgae, and highlight the further ability to
utilize them as tools for manufacture and delivery of therapeutics. Nannochloropsis is quickly
becoming a forerunner in gene knockout and replacement research, paving the way for efforts
to enable enhanced production of desirable fats and other nutritious biological compounds in
other ‘wild’ species [54].
Conclusions
Nannochloropsis sp., Dunaliella sp., Scenedesmus sp., and the CPC exhibited exemplary bio-
chemical profiles rich in high-quality protein, nutritious polyunsaturated fatty acids (such as
ALA, ARA, and EPA), and antioxidant pigments. These properties, in addition to their compa-
rability to commercially produced Chlorella and Spirulina products in basic biochemical com-
position, indicate that these microalgae have great potential for use in human health in a multi-
nutrient capacity. Nannochloropsis sp. is believed to be especially promising as a nutritional
supplement due to the high EPA and astaxanthin levels attained in this study. Productivity,
growth media requirements, environmental tolerances, and other culturing data are already es-
tablished for many of these microalgae, thus progress could proceed to further clinical trialling
of whole-cell or cracked-cell biomass and techno-economic assessment.
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